Literature DB >> 26026304

Efficient RNA delivery by integrin-targeted glutathione responsive polyethyleneimine capped gold nanorods.

Feihu Wang1, Wenjun Zhang2, Yuanyuan Shen2, Qian Huang2, Dejian Zhou3, Shengrong Guo4.   

Abstract

RNA interference (RNAi) mediated gene silencing holds significant promises in gene therapy. A major obstacle to efficient RNAi is the systemic delivery of the therapeutic RNAs into the cytoplasmon without being trapped in intracellular endo-/lyso-somes. Herein we report the development of a PEGylated, RGD peptide modified, and disulfide cross-linked short polyethylenimines (DSPEIs) functionalized gold nanorod (RDG) for targeted small hairpin (sh)RNA delivery. The RDG effectively condensed shRNAs into stable nanoparticles, allowing for highly specific targeting of model human brain cancer cells (U-87 MG-GFP) via the αvβ3 integrins-mediated endocytosis. The combined effects of endosomal escape (via the proton-sponge effect of the PEIs) and efficient cleavage of the disulfide-cross-linked DSPEIs by the high intracellular glutathione content triggered rapid cytoplasma shRNAs release resulting in excellent RNAi efficiency and low cytotoxicity. Furthermore, the high stability and prolonged blood circulation afforded by PEGylation allowed for highly effective, targeted tumor accumulation and internalization of the carriers, resulting in outstanding intra-tumor gene silencing efficiency in U-87 MG-GFP tumor bearing BALB/c mice. Combining the capabilities of both passive and active targeting, intracellular glutathione-triggered "off-on" release and endosomal escape, the RDG nanocarrier developed herein appears to be a highly promising non-viral vector for efficient RNAi.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disulfide-linked polyethylenimine; Glutathione; Gold nanorods; RGD peptide; RNA delivery

Mesh:

Substances:

Year:  2015        PMID: 26026304     DOI: 10.1016/j.actbio.2015.05.028

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  8 in total

Review 1.  Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.

Authors:  Jianing Meng; Vivek Agrahari; Ibrahima Youm
Journal:  J Neuroimmune Pharmacol       Date:  2016-07-23       Impact factor: 4.147

Review 2.  Glycosylation Changes in Brain Cancer.

Authors:  Lucas Veillon; Christina Fakih; Hadi Abou-El-Hassan; Firas Kobeissy; Yehia Mechref
Journal:  ACS Chem Neurosci       Date:  2017-11-07       Impact factor: 4.418

3.  Magnetofection Enhances Adenoviral Vector-based Gene Delivery in Skeletal Muscle Cells.

Authors:  Andrea Soledad Pereyra; Olga Mykhaylyk; Eugenia Falomir Lockhart; Jackson Richard Taylor; Osvaldo Delbono; Rodolfo Gustavo Goya; Christian Plank; Claudia Beatriz Hereñu
Journal:  J Nanomed Nanotechnol       Date:  2016-04-05

Review 4.  Progress and perspectives on targeting nanoparticles for brain drug delivery.

Authors:  Huile Gao
Journal:  Acta Pharm Sin B       Date:  2016-06-14       Impact factor: 11.413

5.  PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.

Authors:  Rui Wang; Volkan Degirmenci; Hongchuan Xin; Ying Li; Liping Wang; Jiayu Chen; Xiaoyu Hu; Dianbao Zhang
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

Review 6.  Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.

Authors:  Ewelina Piktel; Katarzyna Niemirowicz; Marzena Wątek; Tomasz Wollny; Piotr Deptuła; Robert Bucki
Journal:  J Nanobiotechnology       Date:  2016-05-26       Impact factor: 10.435

Review 7.  Recent advances in polymeric drug delivery systems.

Authors:  Yong Kiel Sung; Sung Wan Kim
Journal:  Biomater Res       Date:  2020-06-06

Review 8.  The Peptide Functionalized Inorganic Nanoparticles for Cancer-Related Bioanalytical and Biomedical Applications.

Authors:  Xiaotong Li; Minghong Jian; Yanhong Sun; Qunyan Zhu; Zhenxin Wang
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.